Status:
COMPLETED
EXPLORER PET/CT: Evaluation of Healthy Individuals From Racial/Ethnic Minority Populations
Lead Sponsor:
University of California, Davis
Conditions:
Healthy Volunteers From Racial/Ethnic Minority Populations
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The objective of this pilot study is to collect preliminary data using total body scans on a new, first of its kind, FDA 510k-cleared positron emission tomography/computed tomography (PET/CT) scanner,...
Detailed Description
The aim of this pilot study is to increase the number of healthy individuals from racial/ethnic minority populations. This will advance research being conducted at EMIC by providing "controls" or comp...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- Men and women, 18 years of age or older
- Member of a Federally recognized racial/ethnic minority population, e.g., African American or Black; Hispanic or Latino; Asian American; Native Hawaiian or Other Pacific Islander; Native American or Alaska Native
- Willing and able to fast for at least 6 hours before and for the duration of the scan
- Willing to provide urine samples throughout scan visit
- Willing to provide blood samples for ancestry analysis
- Willing and able to lay motionless in a supine position for up to 60 minutes and for up to 20 minutes at two separate timepoints
- Willing and able to give informed consent, personal contact information (phone number, email and postal address), insurance information, and primary care physician contact
- Exclusion criteria:
- No Primary Care Physician
- No health insurance
- Body weight more than 240 kg (529 pounds)
- Any known concomitant acute infection (including upper respiratory infection, genitourinary infections, etc.)
- History of metastatic or newly (last 5 years) diagnosed locally invasive cancer
- Chemotherapy in the last 5 years
- Radiation therapy in the last 3 years
- Major surgery within the last 6 months
- Pregnancy or breast-feeding
- Diabetes
- Fasting blood glucose level \> 200 mg/dL before administration of fluorodeoxyglucose (FDG)
- Prisoners
- Self-reported history of dysphoria or anxiety in closed spaces
Exclusion
Key Trial Info
Start Date :
August 18 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 8 2021
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT04812080
Start Date
August 18 2021
End Date
November 8 2021
Last Update
April 7 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of California, Davis
Sacramento, California, United States, 95817